Three human NSCLC cell lines: H460, A-549 and H1299 were acquired from American Type Culture Collection (ATCC, Manassas, VA, USA) and were cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco; Thermo Fisher Scientific, Inc., Grand Island, NY, USA) containing 10% fetal bovine serum and penicillin-streptomycin at 37°C under a humidified atmosphere of 5% CO2. Each of the in vitro experiments was performed 3 times. Before transfection, LUAD cells were plated in 96-well plates at 2.5×103 cells/well and maintained at 37°C for 24 h. Blank control, negative mimic control, miR-183-5p mimic, negative inhibitor control and miR-183-5p inhibitor (Ambion; Thermo Fisher Scientific, Inc., Carlsbad, CA, USA) were transfected in LUAD cell lines at a final concentration of 60 nmol/l with Lipofectamine 2000 following the manufacturer's instructions. The concentration for transfections was determined based on previous studies (21 (link),22 (link)). miR-183-5p expression was detected with qPCR in Applied Biosystems PCR 7900 system as stated previously (23 (link)–26 (link)).